Tekron Inc. to Reward Shareholders with Dividend
May 05, 2004 06:30 ET
|
Tekron, Inc.
FORT LAUDERDALE, Fla., May 5, 2004 (PRIMEZONE) -- Tekron Inc. (OTCBB:TKRN) has authorized a one time dividend of 10% to be issued in the form of unregistered stock Rule 144 to all shareholders of...
Tekron, Inc. Announces a $10.5 Million Private Placement
April 28, 2004 06:30 ET
|
Tekron, Inc.
FORT LAUDERDALE, Fla., April 28, 2004 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) today announced that it will offer a US $10.5 million private placement offering of 10,000,000 units at a price of $0.30...
Tekron Inc. Acquires Bioenergy
April 27, 2004 06:30 ET
|
Tekron, Inc.
FORT LAUDERDALE, Fla., April 27, 2004 (PRIMEZONE) -- Tekron Inc. (OTCBB:TKRN) is pleased to announce the acquisition of a 50% capital interest in Bioenergy.
Bioenergy is an Italian corporation...
Tekron Inc. Announces the Application of the Biovirus Technology Platform to SARS
November 20, 2003 06:30 ET
|
Tekron, Inc.
FT. LAUDERDALE, Fla., November 20, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) announces that in light of the current SARS concern in China, Biovirus is proceeding to immediately develop a putative...
Tekron Inc. Announces the Military Applications of the Technology Platform of Biovirus Medical
November 20, 2003 06:30 ET
|
Tekron, Inc.
FT. LAUDERDALE, Fla., Nov. 20, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) announces that Biovirus and Dr. Insell are proceeding with the development of military applications of their combined...
Tekron Inc. Announces the Military Applications of the Technology Platform of Biovirus Medical
November 18, 2003 08:20 ET
|
Tekron, Inc.
FT. LAUDERDALE, Fla., Nov. 18, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) announces that Biovirus and Dr. Insell are proceeding with the development of military applications of their combined...
Tekron, Inc. Announces Partnering of the Technology of Biovirus to Advance the Genomic Computational Analysis Platform
November 13, 2003 06:30 ET
|
Tekron, Inc.
FT. LAUDERDALE, Fla., Nov. 13, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) is proceeding to partner and negotiate licensing for the products and technology platform of Biovirus. Biovirus is using...
Tekron, Inc. Announces Application for a $30 million grant to Advance Herpetic Vaccines Against Herpes Simplex I and II, Marak's Disease, SARS and West Nile Virus
November 11, 2003 06:30 ET
|
Tekron, Inc.
FT. LAUDERDALE, Fla., Nov. 11, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) is undertaking its due diligence of Biovirus, which is proceeding forthwith. It is expected that the deal with Biovirus...
Tekron Inc. Rounds Out Corporate Team for Continued Growth and Expansion with New Director Of Marketing
November 06, 2003 06:30 ET
|
Tekron, Inc.
FORT LAUDERDALE, Fla., Nov. 6, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN)) announces that it has hired Steven J. Weiss as the new Director of Marketing. Mr. Weiss has vast experience in online and...
Tekron, Inc. Announces Entrance into $300 Million Annual Market with the Acquisition of a Minority Interest -- 25% -- of Biovirus, which has Developed a Herpetic Vaccine Against Herpes Simplex I and II
November 05, 2003 07:00 ET
|
Tekron, Inc.
FT. LAUDERDALE, Fla., Nov. 5, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) has inked an agreement with Biovirus, a privately held biotechnology company that has developed both a prophylactic vaccine...